Amunix Funding: $193M Raised, Series B (2021)

Amunix funding overview

Amunix is based in South San Francisco, California. Amunix has raised $193M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in March 2021. The round record for Amunix runs through 2021; nothing later has been disclosed. Investors on record include Viking Global Investors, Frazier Healthcare Partners, Omega Funds, Bain Capital Life Sciences, BlackRock, Franklin Templeton and 13 others. 19 distinct backers are named across the disclosed rounds.

Amunix at a glance

Total raised: $193M
Latest round: Series B
Latest round date: March 2021
Headquarters: South San Francisco, California
Notable investors: Viking Global Investors, Frazier Healthcare Partners, Omega Funds, Bain Capital Life Sciences, BlackRock, Franklin Templeton, Polaris Partners, Redmile Group

Frequently asked about Amunix funding

How much has Amunix raised?: Amunix has raised $193M in total disclosed funding across the rounds on record.
Who has invested in Amunix?: Viking Global Investors, Frazier Healthcare Partners, Omega Funds, Bain Capital Life Sciences, BlackRock, Franklin Templeton are named among the investors backing Amunix.
What was the latest Amunix funding round?: The most recent disclosed round is a Series B, announced in March 2021.
Where is Amunix based?: Amunix is based in South San Francisco, California.
When did Amunix last raise?: The last disclosed Amunix round closed in March 2021 at Series B.

Every Amunix figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in South San Francisco at a similar stage.

Amunix Funding: $193M Raised, Series B (2021)

Amunix funding overview

Amunix at a glance

Frequently asked about Amunix funding

Companies related to Amunix (36)

Browse related funding lists (8)